Exercise or conversion
Karen Firestone
Director
Common Stock
- Value context
- $44K
- Reported price
- $1.76 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
Amylyx Pharmaceuticals, Inc.
Last 30 daysNo qualifying insider buying. Sales: $3.78M by 6 insiders.
Showing the first 6 of 14 trades on this page.
Director
Common Stock
Director
Common Stock
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Financial Officer
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Co-Chief Executive Officer
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Legal Officer
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Medical Officer
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Co-Chief Executive Officer
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Director | Common StockOption exercise or conversion | 25,000$1.76 / share | $44K | Aug 31Filed Sep 2 · 2d later | SEC filing |
| Director | Common StockOption exercise or conversion | 25,000$5.05 / share | $126.25K | Aug 31Filed Sep 2 · 2d later | SEC filing |
| Director | Stock Option (right to buy)Option exercise or conversion | Derivative units25,000$1.76 exercise / conversion price | Not a separate purchase | Aug 31Filed Sep 2 · 2d later | SEC filing |
| Director | Stock Option (right to buy)Option exercise or conversion | Derivative units25,000$5.05 exercise / conversion price | Not a separate purchase | Aug 31Filed Sep 2 · 2d later | SEC filing |
| Chief Financial Officer | Common StockGrant or award | 22,807Award · no purchase price | Non-cash award | Aug 18Filed Aug 20 · 2d later | SEC filing |
| Co-Chief Executive Officer | Common StockGrant or award | 60,039Award · no purchase price | Non-cash award | Aug 18Filed Aug 20 · 2d later | SEC filing |
| Chief Legal Officer | Common StockGrant or award | 21,284Award · no purchase price | Non-cash award | Aug 18Filed Aug 20 · 2d later | SEC filing |
| Chief Medical Officer | Common StockGrant or award | 22,807Award · no purchase price | Non-cash award | Aug 18Filed Aug 20 · 2d later | SEC filing |
| Co-Chief Executive Officer | Common StockGrant or award | 60,039Award · no purchase price | Non-cash award | Aug 18Filed Aug 20 · 2d later | SEC filing |
| Director | Stock Option (right to buy)Grant or award | Derivative units24,372Award · no purchase price | Non-cash award | Jun 4Filed Jun 8 · 4d later | SEC filing |
| Director | Stock Option (right to buy)Grant or award | Derivative units24,372Award · no purchase price | Non-cash award | Jun 4Filed Jun 8 · 4d later | SEC filing |
| Director | Stock Option (right to buy)Grant or award | Derivative units24,372Award · no purchase price | Non-cash award | Jun 4Filed Jun 8 · 4d later | SEC filing |
| Director | Stock Option (right to buy)Grant or award | Derivative units24,372Award · no purchase price | Non-cash award | Jun 4Filed Jun 8 · 4d later | SEC filing |
| Director | Stock Option (right to buy)Grant or award | Derivative units24,372Award · no purchase price | Non-cash award | Jun 4Filed Jun 8 · 4d later | SEC filing |
This reflects the filings imported so far, not a complete trading history.
$12,834 of common-equity purchase value after transaction-age decay across 180 days.
1 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.